2026 NPPES data Pharmacist NPI 1174806061 PHARMACY DOCTORATE
Verify on CMS →

Smitha Dilodilo, PHARMACY DOCTORATE

Pharmacist in Glen Cove, New York. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 290,447 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
32
Medicare Part D claims · 31 beneficiaries · Pharmacist avg: 135
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Smitha Dilodilo, PHARMACY DOCTORATE filed 32 Medicare Part D claims in 2023 as a Pharmacist in Glen Cove, New York, prescribing 0% generic.

32
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Smitha Dilodilo, PHARMACY DOCTORATE's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

32 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Smitha Dilodilo, PHARMACY DOCTORATE?

Quality data not reported

NPI registry status

Active

Issued 09/27/2011

NPI 1174806061

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

32 76% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in New York

How Pharmacist compares to other specialties among New York providers

New York providers

Largest specialties in New York (% of in-state providers)

Student in an Organized Health Care Education/Training Program — 7.8%Student in an Organized Health Care Education/Training Program7.8%Registered Nurse — 5.2%Registered Nurse5.2%Clinical Social Worker — 4.9%Clinical Social Worker4.9%Social Worker — 4.5%Social Worker4.5%Speech-Language Pathologist — 4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse — 4.3%Licensed Practical Nurse4.3%Pharmacist — 4.3%Pharmacist4.3%
Largest specialties in New York (% of in-state providers)

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Smitha Dilodilo, PHARMACY DOCTORATE appears in the CMS NPPES registry as a Pharmacist provider holding PHARMACY DOCTORATE credentials at 93 FOREST AVENUE, Glen Cove, NY, 11542, with a listed phone of (516) 671-4908. NPI 1174806061 was issued on 09/27/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Dilodilo most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 32 prescription claims written by this provider, covering 31 Medicare beneficiaries and totaling roughly $7K in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

93 FOREST AVENUE
Glen Cove, NY 11542

Provider Details

NPI 1174806061
Specialty Pharmacist
Credentials PHARMACY DOCTORATE
Gender Female
NPI Issued 09/27/2011

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to Smitha Dilodilo, PHARMACY DOCTORATE. To verify Smitha Dilodilo, PHARMACY DOCTORATE's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Smitha Dilodilo, PHARMACY DOCTORATE — brand share 100.0%
Pharmacist average

100% brand-name claims vs 0% generic, on 32 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

32
Total Claims
$7K
Total Drug Cost
31
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
32
Total Day Supply
32
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$7K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.01
Gender Split
48% female / 52% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
18
Arexvy
Rsvpref3 Antigen/As01e/Pf
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How Smitha Dilodilo, PHARMACY DOCTORATE fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

Smitha Dilodilo, PHARMACY DOCTORATE's 32 claims are below the specialty average of 135.

Nearby Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Dilodilo.

Compare Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Smitha Dilodilo, PHARMACY DOCTORATE's specialty?
Smitha Dilodilo, PHARMACY DOCTORATE specializes in Pharmacist and practices in Glen Cove, New York. Credentials: PHARMACY DOCTORATE.
How much does Smitha Dilodilo, PHARMACY DOCTORATE prescribe under Medicare Part D?
In 2023, Smitha Dilodilo, PHARMACY DOCTORATE wrote 32 Medicare Part D claims totaling $7K in drug costs for 31 beneficiaries.
Where is Smitha Dilodilo, PHARMACY DOCTORATE located?
Smitha Dilodilo, PHARMACY DOCTORATE is located at 93 FOREST AVENUE, Glen Cove, NY, 11542. Phone: (516) 671-4908.
What is Smitha Dilodilo, PHARMACY DOCTORATE's NPI number?
Smitha Dilodilo, PHARMACY DOCTORATE's National Provider Identifier (NPI) is 1174806061, issued on 09/27/2011.
Does Smitha Dilodilo, PHARMACY DOCTORATE prescribe more brand-name or generic drugs?
Smitha Dilodilo, PHARMACY DOCTORATE's prescribing is 100% brand-name and 0% generic drugs by claim count, with $7K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does Smitha Dilodilo, PHARMACY DOCTORATE prescribe most often?
Based on 2023 Medicare Part D data, Smitha Dilodilo, PHARMACY DOCTORATE's most frequently prescribed drugs include Shingrix, Arexvy. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Smitha Dilodilo, PHARMACY DOCTORATE accept Medicare?
Smitha Dilodilo, PHARMACY DOCTORATE appears in CMS Medicare data with 32 Part D claims and 31 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Smitha Dilodilo, PHARMACY DOCTORATE's credentials?
Smitha Dilodilo, PHARMACY DOCTORATE's NPI is 1174806061 with credentials PHARMACY DOCTORATE. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.